(IN BRIEF) SCHOTT Pharma has reaffirmed its commitment to science-based climate action after the Science Based Targets initiative (SBTi) validated the updated climate targets of the SCHOTT Group, including SCHOTT Pharma’s business scope. The updated framework keeps the Group’s target … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Germany, Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged 1.5°C pathway, 2019 baseline, 27.5 percent Scope 3 reduction, 46.2 percent emissions reduction, Alliance to Zero, Carl Zeiss Foundation, circular economy, Climate Action, climate neutral by 2030, decarbonisation, drug delivery systems, Energize, energy attribute certificates, energy efficiency, EUR 986 million revenue, fiscal year 2030, Frankfurt Stock Exchange, Germany, GHG emissions, glass tubing, greenhouse gas emissions, healthcare value chain, heat recovery, injectable drugs, Lea Kaiser, low-emission melting technologies, Mainz, membrane-based system, natural gas reduction, Paris Agreement, pharmaceutical containment solutions, pharmaceutical quality, product carbon footprint, regulatory requirements, Reinhard Mayer, renewable electricity sourcing, renewable energy, SBTi, SCHOTT Group, SCHOTT Pharma, SCHOTT Pharma Reaffirms Science-Based Climate Action Following SBTi Validation, SCHOTT Pharma Shifts Climate Strategy Toward Measurable Scope 3 Emissions Reductions, SCHOTT Pharma Targets Value Chain Emissions With Updated Science-Based Climate Framework, Science Based Targets initiative, science-based targets, Scope 1 emissions, scope 2 emissions, Scope 3 emissions, secondary packaging, supplier decarbonisation, Switzerland, technological innovation, updated climate targets, value chain emissions, water efficiency, Water for Injection, WFI
(IN BRIEF) SCHOTT Pharma delivered a resilient performance during the first half of fiscal year 2026, reporting revenue growth despite ongoing market challenges and maintaining strong profitability. The company benefited from continued demand for high-value pharmaceutical containment products, especially sterile … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Technology
Tagged biologics, cartriQ BioPure, Christian Mias, drug containment solutions, drug delivery systems, EBITDA, Frankfurt Stock Exchange, Free cash flow, Germany, GLP-1 therapies, Healthcare Innovation, high-value solutions, Hungary, HVS, injectable drugs, Mainz, mRNA Vaccines, pharmaceutical manufacturing, pharmaceutical packaging, polymer syringes, prefillable glass syringes, Reinhard Mayer, SCHOTT Pharma, SCHOTT Pharma Confirms 2026 Outlook Following Resilient First-Half Results and Expansion Investments, SCHOTT Pharma Maintains Stable Growth and Doubles Free Cash Flow in First Half of Fiscal 2026, SCHOTT Pharma Strengthens Financial Position as Demand for High-Value Drug Solutions Continues to Rise, SDAX, specialty vials, sterile cartridges, Switzerland
(IN BRIEF) The German Research Center for Artificial Intelligence (DFKI) and Mainz University Medical Center have initiated the MARK project to understand and predict the biological aging of the immune system using artificial intelligence. Funded by the Rhineland-Palatinate Ministry of … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Germany, Healthcare, News, Pharma & Biotech, Science, Society, Technology
Tagged aging research, AI in medicine, Andreas Dengel, artificial intelligence, biotechnology, blood stem cells, Center for Thrombosis and Hemostasis, Clemens Hoch, data science, DFKI, DFKI and Mainz researchers pioneer AI-driven insights into immune decline and age-related health risks, Germany, healthy aging, immune system aging, Kaiserslautern, life sciences, Mainz, Mainz University Medical Center, MARK project, MARK project combines artificial intelligence and biotechnology to advance healthy aging research in Rhineland-Palatinate, Molecular Analysis of Age-Related Risk Mechanisms, predictive health models, Rhineland-Palatinate Ministry of Science and Health, Wolfram Ruf
(PRESS RELEASE) MUNICH, 5-Jan-2023 — /EuropaWire/ — Technical University of Munich (TUM), one of Europe’s leading universities with focus on the engineering sciences, natural sciences, life sciences, medicine, and social sciences, has announced that an interdisciplinary research team led by … Read the full press release
Posted in Education, Germany, Science, Technology
Tagged 2008, 800-year-old, Bone fragments, corrosion, Dr. Burkhard Schillinger, gold-plated pendant, interdisciplinary research team, jewelry, Leibniz-Zentrum für Archäologie (LEIZA), LEIZA, linen, lock mechanism, Mainz, Matthias Heinzel, medieval pendant, medieval refuse pit, neutrons, non-destructive examinations, Old City, Prompt Gamma Activation Analysis (PGAA), Research Neutron Source Heinz Maier-Leibnitz (FRM II), restorer, silk, Technical University of Munich (TUM), tomographies
27-9-2013 — /EuropaWire/ — With one of Coface’s priorities being safer trade for companies, the Group is continuing to develop its risk expertise by setting up an international network of economists in strategic regions (based in Hong Kong, Mainz, Istanbul, Sao … Read the full press release
Posted in Business, Economy, Financial, France, Insurance, Investment
Tagged COFACE, economic risk, economists, Hong Kong, İstanbul, Mainz, safer trade, São Paulo, Warsaw, Yves Zlotowski
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?